Safety and efficacy of Hansenula-derived PEGylated-interferon alpha-2a and ribavirin combination in chronic hepatitis C Egyptian children

doi:10.3748/wjg.v20.i16.4681

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 16

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6906)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-6) series.

Item

Count

PDF

389

WORD

296

HTML

3541

Figures (1-2)

161

Tables (1-6)

149

Sum=4536

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1419

Download

951

Sum=2370

Apr 28, 2014 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Apr 28, 2014; 20(16): 4681-4691
Published online Apr 28, 2014. doi: 10.3748/wjg.v20.i16.4681

Table 2 Response outcome

Response type	n = 46
End of treatment response	13 (28.2)
SVR	11 (23.9)
Dropped out SVR	2 (4.3)
Non-responder	14 (30.4)
Breakthrough	18 (39.1)
Delayed responders ended by breakthrough	8 (17.4)
Breakthrough ended at 48 wk as non-responders	8 (17.4)
Breakthrough ended at 72 wk by relapse	2 (4.3)
Relapse	1 (2.17)

Two patients who had end of treatment response (ETR) but were lost to follow up. SVR: Sustained virological response.

Citation: Naghi SE, Abdel-Ghaffar TY, El-Karaksy H, Abdel-Aty EF, El-Raziky MS, Allam AA, Helmy H, El-Araby HA, Behairy BE, El-Guindi MA, El-Sebaie H, Abdel-Ghaffar AY, Ehsan NA, El-Hennawy AM, Sira MM. Safety and efficacy of Hansenula-derived PEGylated-interferon alpha-2a and ribavirin combination in chronic hepatitis C Egyptian children. World J Gastroenterol 2014; 20(16): 4681-4691
URL: https://www.wjgnet.com/1007-9327/full/v20/i16/4681.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i16.4681